Director, Health Economics and Market Access - Robotics and Interventional Solutions

Johnson & Johnson is recruiting a Director, Health Economics & Market Access (HEMA) for the Johnson & Johnson MedTech Surgery business with a focus on the Robotics and Interventional Solutions platforms. This position is preferred to be located in Santa Clara, CA; Alternate Locations such as Cincinnati, OH; Raritan, NJ or Markham, CA may be considered for qualified candidates. Remote work options may be considered, on a case-by-case basis and if approved by the Company.

At Johnson & Johnson,?we believe health is everything. Our strength in healthcare innovation empowers us to build a?world where complex diseases are prevented, treated, and cured,?where treatments are smarter and less invasive, and?solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

The Director, Health Economics & Market Access for the Robotics and Interventional Solutions platforms, reporting to the Senior Director, HEMA for Energy/Endomech/Robotics, will work in close collaboration with Global Strategic Marketing, Research & Development, Medical, Clinical & Preclinical, and Regional HEMA partners to build and execute fully integrated health economic and market access strategies for the Robotics and Interventional Solutions platforms.

This is a critical leadership role that will (i) shape the market access strategies that include but are not limited to assessing market access needs/trends, (ii) influence the business strategies to leverage market access considerations in the respective therapeutic areas, and (iii) develop and execute required market access and evidence of value strategies to optimize market access, adoption, and commercial success.

This role will work closely with R&D and Clinical teams to ensure that HEMA criteria are considered during product development and in clinical trials. They will work closely with regional HEMA partners to ensure that key regional market access requirements are represented in all strategies and will have responsibility for setting overall US market access strategy.

The Director serves as a member and contributor to various cross-functional teams, providing functional expertise and leadership, and actively contributes to the business as a whole. Cross functional partners include R&D, GSM, US marketing, Business Development, Medical Affairs, Clinical Research, Regional HEMA & Marketing, Regulatory Affairs, HCC and Legal.

Specific responsibilities include:

• Lead the design and implementation of health economics, pricing, and reimbursement research for their respective platforms.
• Evaluate the economic value of products and therapies with clinical and quality of life outcomes data from clinical trials and/or epidemiology studies.
• Support the development and execution of lifecycle economic evidence and market access strategies that enable market access and commercial success.
• Represent the voice of external, non-clinical stakeholders, such as payers and providers; ensure that market access requirements are understood and built into the product pipeline through Target Product Profiles and value propositions that reflect the needs of non-clinical stakeholders for their respective platforms.
• Lead market access activities that include but are not limited to assessing market access needs/trends and developing required market access strategies to optimize market access and commercial success.
• Partner with regions and key geographies to ensure value messages are clearly cascaded and supported by appropriate tools and evidence.
• Manage research activities that include but are not limited to the burden of illness, retrospective database studies, creation of global economic models and value messaging, patient-reported outcomes development and analysis, interpretation of economic, satisfaction and QoL endpoints and results, and training on dissemination tools.
• Work collaboratively with regional HEMA teams to identify evidentiary requirements and potential barriers to access and to secure positive endorsement when applicable from HTA agencies.